EVVIVAX
EVVIVAX is a biotechnology company that pursues the discovery and development of innovative therapeutic veterinary cancer vaccines based on viral vectors and DNA platform technologies. The company engineers the antigens and use combinations of different genetic immunization modalities (heterologous prime/boost) as a powerful approach to induce superior immune responses and achieve greater clinical efficacy. they also offer services such as electrochemotherapy, in vivo electroporation, genetic vaccine, electro-gene-transfer, and vet-eporatorTM. Its headquarters is located in Rome, Italy and was founded in 2016 by Luigi Aurisicchio.
EVVIVAX
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics Veterinary Wellness
Founded:
2016-06-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Euro PHP PHP 7 COVID-19 CPanel SSL
Similar Organizations
Asclepia
ASCLEPIA is a Medicinal Chemistry oriented Research & Services by designing innovative, therapeutically relevant, druglike compounds.
Exeter Antioxidant Therapeutics Ltd.
Exeter Antioxidant Therapeutics Ltd. is a young, dynamic company established to further the development of therapeutic catalysts.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Pharmacure Health Care International AB
Pharmacure focuses on the development of new drug to improve the therapeutic the enhancing nasal comfort of our patients.
Swords Labs
Bristol-Myers Squibb is a biopharma company that works to discover, and deliver innovative medicines that help patients fight disease.